Sustainability performance
We have developed targets and are measuring performance to drive impact across our three key areas of focus.
:quality(90)/)
Access to innovation
We want to maximise access to our innovation and support equitable health outcomes for patients worldwide.
:quality(90)/)
People
We are committed to fostering a work environment where all people are valued and have the opportunity to thrive.
:quality(90)/)
Environment
We aim to make a positive and meaningful contribution to the health of nature, water systems, climate & people.
Access to innovation targets
3x
Triple number of patients treated with our strategic pharmaceuticals portfolio by 2029 (base year 2023).
2x
Double number of patients reached with our high-medical-value diagnostics solutions by 2029 (base year 2020).
2x
Double number of patients receiving our core pharmaceutical therapies in low- and lower-middle-income countries* by 2026 (base year 2021).
3x
Triple societal impact delivered with our strategic pharmaceuticals portfolio by 2029 (base year 2023).
Access to innovation key achievements
![[Icon]](https://assets.roche.com/f/176343/2918x2918/f8931cdf3b/patient.png/m/320x0/filters:format(webp):quality(90)/)
XXX million +
patients treated with our strategic pharmaceuticals portfolio in 2025.
![[Icon]](https://assets.roche.com/f/176343/2918x2918/d8177f774f/sample_handling.png/m/320x0/filters:format(webp):quality(90)/)
XXX million +
patients reached with our high-medical value diagnostics solutions in 2025.
![[Icon]](https://assets.roche.com/f/176343/2918x2918/96895ea84e/patient_safety.png/m/320x0/filters:format(webp):quality(90)/)
59,000+
Patients in low- and lower-middle-income countries* received our core pharmaceutical therapies in 2025, compared to 27,000 in 2021 - achieving our goal one year ahead of schedule.
*Low- and lower-middle-income countries covered by our access goal are Egypt, Indonesia, Morocco, and Vietnam.
People targets
> 75
Health and Well-being Index score in our global employee survey by 2029.
> 80
Inclusion Index score in our global employee survey by 2029.
People key achievements
![[Icon]](https://assets.roche.com/f/176343/2917x2917/0594cef4f6/icon2.png/m/320x180/filters:format(webp):quality(90)/)
![[Icon]](https://assets.roche.com/f/176343/2917x2917/e78f795246/sustainability-in-general-social.png/m/320x180/filters:format(webp):quality(90)/)
XX
Health and Well-being Index score in 2025
XX
Inclusion Index score in 2025
Climate change targets
We recognise climate change as one of the largest global risks and are committed to addressing it as a matter of urgency. We are committed to achieving net zero carbon emissions by 2045 and have set near- and long-term targets validated by SBTi.
Net zero GHG emissions across the value chain (scope 1-3) by 2045
Absolute zero GHG emissions in own operations (scope 1-2) by 2050
:quality(90)/)
- 22.5%
in absolute scope 3*
GHG emissions by 2029 (base year 2022).
- 70%
in absolute scope 1 and 2
GHG emissions by 2029 (base year 2022).
- 22.5%
in absolute scope 3*
GHG emissions by 2029 (base year 2022).
70%
of suppliers to have
science-based targets
by 2029.
100%
sustainable electricity
at all sites**
by 2029.
*From fuel & energy, waste from company operations and business travel, as well as from the use of sold products and the end of life of sold products.
**All sites with at least 30 employees or an estimated annual energy consumption of 100 gigajoules or higher. Includes manufacturing facilities and lab sites.
Read more about our detailed environmental goals.
Climate change key achievements
Scope 1 & 2 GHG emissions
:quality(90)/)
Scope 1, 2 and 3 long-term goal
Scope 3 GHG emissions
Supplier engagement
100% sustainable electricity across our operations in 2025.
:quality(90)/)
Product sustainability targets
Reducing GHG emissions
by 22.5% from product use and end-of-life treatment by 2029 (base year 2020).
Reducing product environmental impact
by 50% by 2029 - measured by Product Sustainability Performance tool (PSP) (base year 2020).
Integrating sustainability criterias
by 2028 for all product-related decision making processes across the product life cycle.
Meeting sustainability criterias
of their product family for all products by 2045.
Product sustanability key achievements
![[Icon]](https://assets.roche.com/f/176343/2917x2917/c4e5534393/cloud_download.png/m/320x0/filters:format(webp):quality(90)/)
GHG emission from product use and end-of-life treatment
Embedding eco-design and recyclability improvements across the product life cycle.
Increasing energy efficiency in diagnostic equipment during the use phase
:quality(90)/)
Environmental impact of our products
Measuring progress with a subset of products that represent the product portfolio.
Defining broad sustainability criteria for all Roche products.
:quality(90)/)
Embedding sustainability into product decision-making
Embedding product sustainability criteria into product design processes.
Integrating PSP scoring into product governance.
Expanding the application of life cycle assessment methodologies.
Advancing product sustainability criteria
Expanding application of product sustainability criteria to all products.
Establishing improvement targets by product family.
Biodiversity and water targets
Certified for biodiversity and water stewardship
by 2030 of relevant Roche sites and key suppliers through their projects.
Procuring from credible certified sources
by 2030 for key natural commodities.
Incorporating true costs
of water and natural commodities into business decisions by 2045.
Reduction in phosphorus emissions
to wastewater by 64% by 2029 (base year 2025).
Reduction in Roche's risk-weighted water consumption
by -5% by 2029 (base year 2025).
Read more about our detailed environmental goals.
Biodiversity and water key achievements
![[Icon]](https://assets.roche.com/f/176343/2917x2917/7c18440f13/protection_on.png/m/320x0/filters:format(webp):quality(90)/)
Biodiversity and water stewardship certification
Defining high-risk sites and suppliers guided by using the SBTN-aligned methodology.
Pursuing water stewardship certification.
:quality(90)/)
Certified sourcing of key natural commodities
Defining our key natural commodities through an assessment guided by the SBTN and TNFD frameworks.
Identifying high-impact materials and evaluating available certification schemes
:quality(90)/)
True cost of water and natural commodities
Developing methodologies and baseline data to capture the real cost of water- and nature- related dependencies, which will inform future strategic decisions.
:quality(90)/)
Reduction of phosphorus emissions to wastewater
Minimising pollution of nutrient discharge to receiving waters.
:quality(90)/)
Water efficiency
Tailored initiatives being implemented at sites to improve water efficiency, including water recycling, closed-loop systems and efficiency upgrades.
:quality(90)/)